Method of assaying Apolipoprotein AI for the in vitro diagnosis of colorectal cancer
US10591482B2 · kind B2 · utility
0Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2017 |
| Grant date | Mar 17, 2020 |
| Priority date | — |
| Expiry date | Sep 13, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/775
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method assaying the levels of expression Apolipoprotein AI, Apolipoprotein AII, E-Cadherin, and Galectin-3 in a biological sample from a person having or suspected of having colorectal cancer. The sample is remote from any tumor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.